The effectiveness and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early-stage human epidermal growth factor receptor 2-positive breast cancer: Turkish Oncology Group study.

Details

Language :

English

ISSN :

09594973

Volume :

33

Issue :

7

Database :

Complementary Index

Journal :

Anti-Cancer Drugs

Publication Type :

Academic Journal

Accession number :

157959721

Full Text :

https://doi.org/10.1097/CAD.0000000000001310